Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.760
-0.040 (-1.05%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Quantum BioPharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Selling, General & Admin | 8.67 | 9.03 | 14.45 | 15.93 | 10.06 | 8.41 | Upgrade
|
| Research & Development | 1 | 3.86 | 6.91 | 6.33 | 7.83 | - | Upgrade
|
| Operating Expenses | 10.59 | 19.23 | 27.43 | 33.74 | 29.84 | 22.43 | Upgrade
|
| Operating Income | -10.59 | -19.23 | -27.43 | -33.74 | -29.84 | -22.43 | Upgrade
|
| Interest Expense | -0.02 | -0 | -0.05 | -0.07 | -0.24 | -0.16 | Upgrade
|
| Interest & Investment Income | 0.6 | 0.79 | 0.37 | 0 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.12 | 0.21 | 0.52 | 0.68 | 2.56 | -2.64 | Upgrade
|
| EBT Excluding Unusual Items | -9.88 | -18.24 | -26.59 | -33.13 | -27.51 | -25.23 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.1 | -0.38 | -0.23 | -0.86 | -0.77 | -8.78 | Upgrade
|
| Asset Writedown | -0.24 | -4.56 | - | - | -0.09 | -0.05 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.76 | - | Upgrade
|
| Other Unusual Items | 1.99 | 4.94 | 0.12 | 0.05 | 0.68 | -0.02 | Upgrade
|
| Pretax Income | -8.23 | -18.23 | -26.7 | -33.94 | -28.45 | -34.08 | Upgrade
|
| Earnings From Continuing Operations | -8.23 | -18.23 | -26.7 | -33.94 | -28.45 | -34.08 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 3.1 | -1.35 | -3.35 | -5.05 | Upgrade
|
| Net Income to Company | -8.23 | -18.23 | -23.61 | -35.29 | -31.8 | -39.13 | Upgrade
|
| Minority Interest in Earnings | 0.76 | 0.33 | - | - | - | - | Upgrade
|
| Net Income | -7.47 | -17.9 | -23.61 | -35.29 | -31.8 | -39.13 | Upgrade
|
| Net Income to Common | -7.47 | -17.9 | -23.61 | -35.29 | -31.8 | -39.13 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 3.11% | 2.21% | 10.84% | 190.15% | 70.68% | 19.49% | Upgrade
|
| EPS (Basic) | -12.05 | -29.39 | -39.62 | -65.63 | -171.62 | -360.45 | Upgrade
|
| EPS (Diluted) | -12.05 | -29.39 | -39.62 | -65.63 | -171.62 | -360.45 | Upgrade
|
| Free Cash Flow | -5.14 | -10.83 | -28.45 | -20.75 | -19.13 | -13.71 | Upgrade
|
| Free Cash Flow Per Share | -8.30 | -17.78 | -47.74 | -38.59 | -103.25 | -126.32 | Upgrade
|
| EBITDA | -10.06 | -16.73 | -22.9 | -29.7 | -25.94 | -20.49 | Upgrade
|
| D&A For EBITDA | 0.53 | 2.51 | 4.53 | 4.05 | 3.9 | 1.94 | Upgrade
|
| EBIT | -10.59 | -19.23 | -27.43 | -33.74 | -29.84 | -22.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.